Tags : High-Dose Quadrivalent

Sanofi’s Fluzone High-Dose Quadrivalent (Influenza Vaccine) Receives the FDA’s Approval

Shots: The sBLA approval is based on P-III immunogenicity and safety study assessing Fluzone High-Dose Quadrivalent vs two trivalent formulations of Fluzone High-Dose in 32,000 adults aged≥ 65yrs. over two influenza seasons in the US and Canada The P-III results demonstrated that Fluzone High-Dose Quadrivalent prevent 24% more cases of influenza caused by any circulating influenza strain […]Read More